首页
订购/客服:400-666-5481

埃格列净

    
≥98%

PF-04971729

源叶(MedMol)
S82363 一键复制产品信息
1210344-57-2
C22H25ClO7
436.88
1,6-脱水-1-C-[4-氯-3-[(4-乙氧基苯基)甲基]苯基]-5-C-(羟基甲基)-beta-L-艾杜糖;PF04971729;PF 04971729;PF-04971729
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S82363-5mg促销
≥98%

¥1300.00 ¥1040.00

10 3 - - -
S82363-10mg促销
≥98%

¥1970.00 ¥1580.00

10 - - - -
S82363-50mg促销
≥98%

¥7370.00 ¥5900.00

9 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2. Has the potential for the treatment of type 2 diabetes mellitus
靶点: SGLT2;SGLT
体内研究: Ertugliflozin (PF-04971729) reveals a concentration-dependent glucosuria after oral administration to rats
参考文献: 1. Mascitti V, et al. Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors. J Med Chem. 2011 Apr 28;54(8):2952-60. 2. Miao Z, et al. Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects. Drug Metab Dispos. 2013 Feb;41(2):445-56. 3. Kalgutkar AS, et al. Preclinical species and human disposition of PF-04971729, a selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type 2 diabetes mellitus. Drug Metab Dispos. 2011 Sep;39(9):1609-19.
溶解性: Soluble  in  DMSO
保存条件: -20°C;充氩
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.289 ml 11.445 ml 22.89 ml
5 mM 0.458 ml 2.289 ml 4.578 ml
10 mM 0.229 ml 1.144 ml 2.289 ml
50 mM 0.046 ml 0.229 ml 0.458 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×